- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Armadale Capital: Mahenge graphite Scoping Study Delivers NPV of US$349m with 122 percent IRR
Armadale, the AIM quoted investment company focused on natural resource projects in Africa, is pleased to announce the results of the Scoping Study completed by BatteryLimits on the Mahenge Liandu Graphite Project in Tanzania (‘Mahenge’ or the ‘Project’), which demonstrates highly robust and compelling economics. As quoted in the press release: Nick Johansen, Director of …
Armadale, the AIM quoted investment company focused on natural resource projects in Africa, is pleased to announce the results of the Scoping Study completed by BatteryLimits on the Mahenge Liandu Graphite Project in Tanzania (‘Mahenge’ or the ‘Project’), which demonstrates highly robust and compelling economics.
As quoted in the press release:
Nick Johansen, Director of Armadale said: “We have long held confidence in the commercial potential and economic value of Mahenge and the results of this Scoping Study greatly reinforces this view. The Project’s NPV of US$US349m is significant, especially when compared to our current market cap of ~£5m. With an IRR of 122%, 1.2 year payback and low development costs, we firmly believe that Mahenge is an attractive asset for development. Crucially, the Scoping Study was limited to just 25% of the Project’s current resource, which forms Stage 1 of a planned staged development programme. Accordingly, with an upgrade in throughput there is significant potential to improve the Project economics even further. Our next steps will now be to commence a definitive feasibility study so that we can advance Mahenge to a decision to mine early in 2019.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.